News

Quest Diagnostics launches AD-Detect blood test for Alzheimer’s confirmation
Quest Diagnostics (DGX) launched a new laboratory blood test designed to help physicians confirm amyloid brain pathology due to Alzheimer’s ...
Medical Device Network on MSN8d
Quest introduces blood test to confirm amyloid brain pathology in Alzheimer’s
Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...
Nasdaq9d
Quest Diagnostics Launches New Blood Test To Confirm Alzheimer's Disease
(RTTNews) - Quest Diagnostics (DGX), Wednesday announced the launch of a new blood test designed to confirm amyloid brain pathology due to Alzheimer's disease (AD) in patients with mild cognitive ...
Yahoo Finance17d
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Quest Diagnostics Incorporated logo ... RHHBY), approved for use with Roche's cobas® HPV test in May 2024. Interested patients can opt for self-collection in clinical settings, such as a ...